Related Experiment Video
Updated: Oct 2, 2025

Chemical Dimerization-Induced Protein Condensates on Telomeres
Published on: April 12, 2021
Deneddylation of PML/RARα reconstructs functional PML nuclear bodies via orchestrating phase separation to eradicate
Xuejing Shao1, Yingqian Chen1, Aixiao Xu1
1Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Abstract:
Acute promyelocytic leukemia (APL) is driven by the oncoprotein PML/RARα, which destroys the architecture of PML nuclear bodies (NBs). PML NBs are critical to tumor suppression, and their disruption mediated by PML/RARα accelerates APL pathogenesis. However, the mechanisms of PML NB disruption remain elusive. Here, we reveal that the failure of NB assembly in APL results from neddylation-induced aberrant phase separation of PML/RARα. Mechanistically, PML/RARα is neddylated in the RARα moiety, and this neddylation enhances its DNA-binding ability and further impedes the phase separation of the PML moiety, consequently disrupting PML NB construction. Accordingly, deneddylation of PML/RARα restores its phase separation process to reconstruct functional NBs and activates RARα signaling, thereby suppressing PML/RARα-driven leukemogenesis. Pharmacological inhibition of neddylation by MLN4924 eradicates APL cells both in vitro and in vivo. Our work elucidates the neddylation-destroyed phase separation mechanism for PML/RARα-driven NB disruption and highlights targeting neddylation for APL eradication.
Insights
Neddylation disrupts PML nuclear bodies in acute promyelocytic leukemia (APL) by altering PML/RARα phase separation. Inhibiting neddylation with MLN4924 eradicates APL cells, offering a new therapeutic strategy.
Area of Science:
- Cell Biology
- Molecular Oncology
- Biochemistry
Background:
- Acute promyelocytic leukemia (APL) is driven by the PML/RARα oncoprotein.
- PML/RARα disrupts PML nuclear bodies (NBs), which are crucial for tumor suppression.
- The precise mechanisms underlying PML NB disruption in APL are not fully understood.
Purpose of the Study:
- To elucidate the molecular mechanisms by which PML/RARα disrupts PML nuclear bodies in APL.
- To investigate the role of neddylation in the aberrant phase separation of PML/RARα.
- To evaluate the therapeutic potential of targeting neddylation in APL.
Main Methods:
- Investigated the phase separation properties of PML/RARα.
- Analyzed the effect of neddylation on PML/RARα DNA-binding and phase separation.
- Utilized pharmacological inhibition of neddylation (MLN4924) in vitro and in vivo APL models.
Main Results:
- Neddylation of PML/RARα in the RARα moiety enhances DNA binding and disrupts PML NB assembly via aberrant phase separation.
- Deneddylation of PML/RARα restores phase separation, reconstructs functional NBs, and activates tumor-suppressive signaling.
- MLN4924 treatment effectively eradicated APL cells in both in vitro and in vivo experimental settings.
Conclusions:
- Neddylation-induced phase separation defects of PML/RARα are a key mechanism for PML NB disruption in APL.
- Targeting the neddylation pathway presents a promising therapeutic strategy for APL eradication.
- Restoring PML NB integrity through deneddylation suppresses leukemogenesis.
Related Concept Videos
Abnormal Proliferation
Disassembly of Intermediate Filaments
Keratin proteins, found at the cell periphery near cell junctions, undergo a cycle of assembly and disassembly. In Type...
Restarting Stalled Replication Forks
Anaphase Promoting Complex
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle

